Rapid Dose Therapeutics Management
Management criteria checks 3/4
Rapid Dose Therapeutics' CEO is Mark Upsdell, appointed in May 2017, has a tenure of 7.33 years. total yearly compensation is CA$150.00K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 9.64% of the company’s shares, worth CA$1.86M. The average tenure of the management team and the board of directors is 6 years and 2 years respectively.
Key information
Mark Upsdell
Chief executive officer
CA$150.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 7.3yrs |
| CEO ownership | 9.6% |
| Management average tenure | 6yrs |
| Board average tenure | 2yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| May 31 2024 | n/a | n/a | -CA$5m |
| Feb 29 2024 | CA$150k | CA$150k | -CA$4m |
| Nov 30 2023 | n/a | n/a | -CA$4m |
| Aug 31 2023 | n/a | n/a | -CA$3m |
| May 31 2023 | n/a | n/a | -CA$3m |
| Feb 28 2023 | CA$156k | CA$150k | -CA$4m |
| Nov 30 2022 | n/a | n/a | -CA$9m |
| Aug 31 2022 | n/a | n/a | -CA$10m |
| May 31 2022 | n/a | n/a | -CA$9m |
| Feb 28 2022 | CA$212k | CA$150k | -CA$8m |
| Nov 30 2021 | n/a | n/a | -CA$2m |
| Aug 31 2021 | n/a | n/a | -CA$2m |
| May 31 2021 | n/a | n/a | -CA$1m |
| Feb 28 2021 | CA$100k | CA$100k | -CA$2m |
| Nov 30 2020 | n/a | n/a | -CA$2m |
| Aug 31 2020 | n/a | n/a | -CA$5m |
| May 31 2020 | n/a | n/a | -CA$5m |
| Feb 29 2020 | CA$765k | CA$272k | -CA$8m |
| Nov 30 2019 | n/a | n/a | -CA$17m |
| Aug 31 2019 | n/a | n/a | -CA$15m |
| May 31 2019 | n/a | n/a | -CA$14m |
| Feb 28 2019 | CA$344k | CA$292k | -CA$11m |
| Nov 30 2018 | n/a | n/a | -CA$3m |
| Aug 31 2018 | n/a | n/a | -CA$2m |
| Feb 28 2018 | CA$412k | CA$341k | -CA$2m |
Compensation vs Market: Mark's total compensation ($USD111.30K) is below average for companies of similar size in the Canadian market ($USD178.08K).
Compensation vs Earnings: Mark's compensation has been consistent with company performance over the past year.
CEO
Mark Upsdell
7.3yrs
Tenure
CA$150,000
Compensation
Mr. Mark Andrew Upsdell is the Chief Executive Officer and Director of Rapid Dose Therapeutics Corp. since May 03, 2017 and he served as its Chairman. He serves as President of Rapid Dose Therapeutics Corp...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7.3yrs | CA$150.00k | 9.64% CA$ 1.9m | |
| Chief Financial Officer | 4.6yrs | CA$157.75k | no data | |
| Senior Vice President of Business Development | 7.3yrs | CA$150.00k | no data | |
| Chief Scientist | 1.1yrs | no data | no data | |
| Legal Counsel | no data | no data | no data | |
| Controller | no data | no data | no data | |
| Assistant Corporate Secretary | no data | no data | no data |
6.0yrs
Average Tenure
Experienced Management: DOSE's management team is seasoned and experienced (6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 7.3yrs | CA$150.00k | 9.64% CA$ 1.9m | |
| Independent Director | 1.4yrs | CA$17.49k | 0.55% CA$ 106.8k | |
| Independent Director | 4.1yrs | CA$47.41k | 0.11% CA$ 21.5k | |
| Member Medical of Advisory Board | 2.7yrs | no data | no data | |
| Independent Director | 1.1yrs | CA$17.49k | 0.053% CA$ 10.1k | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Independent Director | 1.1yrs | CA$17.49k | no data | |
| Member of Advisory Board | 2.8yrs | no data | no data | |
| Independent Director | less than a year | CA$17.49k | 0.45% CA$ 86.9k |
2.0yrs
Average Tenure
Experienced Board: DOSE's board of directors are not considered experienced ( 2 years average tenure), which suggests a new board.